PMA device
Entrust ICD
Medtronic Cardiac Rhythm Disease Management · Implantable Cardioverter Defibrillator (Non-Crt) (LWS, Class III) · First FDA decision May 9, 2008, newest Feb 14, 2014Ventricular arrhythmia and sudden cardiac arrest
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
5
PMA pathway
Device trials
5
Naming "Entrust ICD"
MAUDE reports
0
Brand "Entrust ICD", since 2015
PubMed studies
0
Mentioning "Entrust ICD"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Entrust ICD
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 5 of 5 decisions filed under this name.
- ENTRUST ICD, INTRINSIC 30ICD, MARQUIS DR ICD, VR ICD, MAXIMO DR ICD, VR ICD, EVERA S DR ICD, S VR ICD,XT VR ICD, MAXIMOPMA supplement
P980016-S436 · Decided Feb 14, 2014 · 175 days after receipt · Normal 180 Day Track
Device type: Implantable cardioverter defibrillator (non-CRT) (LWS) · Cardiology
- ENTRUST ICD, INTRINSIC 30 ICD, INTRINSIC ICD, INTRINSIC ICD, MARQUIS DR ICD, MARQUIS VR ICD, MAXIMO DR ICD, MAXIMO VR ICPMA supplement
P980016-S400 · Decided May 24, 2013 · 87 days after receipt · Normal 180 Day Track
Device type: Implantable cardioverter defibrillator (non-CRT) (LWS) · Cardiology
- ENTRUST ICD, PROTECTA DF4 ICD, ICD, XT DF4 ICD, ICD, SECURA DF4 ICD, SECURA ICD, VIRTUOSO ICD VIRTUOSO II DR/VR ICDPMA supplement
P980016-S357 · Decided Mar 26, 2013 · 217 days after receipt · Normal 180 Day Track
Device type: Implantable cardioverter defibrillator (non-CRT) (LWS) · Cardiology
2 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Implantable Cardioverter DefibrillatorsNational analysisReview closedCAG-00157R4Updated Nov 19, 2026
- Implantable Cardioverter Defibrillators (ICDs)National determinationOn the books20.4Updated Sep 28, 2026
- Implantable Cardioverter Defibrillators (ICDs)National analysisReview closedCAG-00157NUpdated Sep 15, 2026
- Surveillance of Implantable or Wearable Cardioverter Defibrillators (ICDs): Office, Hospital, Web, or Non-Web BasedLocal determinationIn effectL34087CGS Administrators, LLCUpdated Aug 28, 2026
- Implantable DefibrillatorsNational analysisReview closedCAG-00157R2Updated Nov 19, 2026
- Implantable Defibrillators - Clinical TrialsNational analysisReview closedCAG-00157RUpdated Sep 15, 2026
- Implantable DefibrillatorsNational analysisReview closedCAG-00157R3Updated Sep 15, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Entrust ICD", any status and sponsor, newest update first.
- Comparison of VF Induction Techniques During Medtronic ICD Implant (VF) (ICD)Pivotal-lookingCompleted
James MerrillAcademic, hospital or other
NCT02027883 · 100 participants · Start Jan 2011 · Primary completion Aug 2012
Device: Nominal T shock setting; Educated T shock setting · For: Cardiomyopathy
Sites: Kingsport, Tennessee
Mayo ClinicAcademic, hospital or other
NCT00589303 · 27 participants · Start Dec 2007 · Primary completion Jul 2011
Device: AV Node ablation and device implant · For: Atrial Fibrillation; Heart Failure
Sites: Scottsdale, Arizona; Evansville, Indiana; Rochester, Minnesota · 6 sites in all
- RIGHT: Rhythm ID Going Head-to-Head TrialPivotal-lookingCompleted
Boston Scientific CorporationPublic (BSX)
NCT00148954 · 1,962 participants · Start Jul 2005 · Primary completion Mar 2009
Device: VITALITY 2 Implantable Cardioverter Defibrillator; Medtronic Implantable Cardioverter Defibrillator · For: Tachycardia
Sites: Charleston, South Carolina
2 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Entrust ICD", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code LWS
240,687 reports: 89,252 malfunction, 148,026 injury, 3,316 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2127-2025 · Started Jun 17, 2025 · Posted by FDA Jul 17, 2025
Reason given: A software update for Medtronic CareLink SmartSync Device Manager (SmartSync) is now available. The update eliminates the potential display of an erroneous electrical reset (pop-up) message upon interrogation with a SmartSync Device Manager. The erroneous message indicates an electrical reset has occurred. However, no...
Cause as FDA categorized it: Software design · Device type: Programmer, Pacemaker (KRG)
Z-2128-2025 · Started Jun 17, 2025 · Posted by FDA Jul 17, 2025
Reason given: A software update for Medtronic CareLink SmartSync Device Manager (SmartSync) is now available. The update eliminates the potential display of an erroneous electrical reset (pop-up) message upon interrogation with a SmartSync Device Manager. The erroneous message indicates an electrical reset has occurred. However, no...
Cause as FDA categorized it: Software design · Device type: Programmer, Pacemaker (KRG)
- ICD-VR DVEX2E4 EV ICD OUS EV4, Model Number DVEX2E4; Implantable Cardioverter DefibrillatorsOpen, Classified
Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
Z-1801-2023 · Started May 10, 2023 · Posted by FDA Jun 16, 2023
Reason given: There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds) manufactured with a specific (glassed) feedthrough, including currently available ICDs and CRT-Ds.
Cause as FDA categorized it: Under Investigation by firm · Device type: Implantable Cardioverter Defibrillator (Non-Crt) (LWS)
11 more recall records with a free account
Published research
The most relevant PubMed records for "Entrust ICD"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code LWS.
- Evera MRI XT DR SureScan Model DDMB1D4Medtronic Cardiac Rhythm Disease Management · PMA 2022
- CurrentAbbott Medical · PMA 2026
- Subcutaneous Implantable Cardioverter Defibrillator (S-ICD)Boston Scientific Corporation · PMA 2022
- Evera S Dr,s Vr Xt Dr, Xt Ve,icd'sMedtronic Cardiac Rhythm Disease Management · PMA 2016
- Gem III At ICDMedtronic, Inc. · PMA 2016
- EMBLEM S-ICD Electrode (Lead) Model 3501Boston Scientific Corporation · PMA 2026
- ENDOTAK RELIANCE / RELIANCE 4-FRONT pace/sense defibrillation leadsBoston Scientific · PMA 2026
- Sprint Quattro Secure S MRI Surescan Lead Model 6935M,SPRINT Quattro Secure MRI Surescan Lead Model 6947MMedtronic, Inc. · PMA 2016
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.